Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2

The development of effective vaccines that can be rapidly manufactured and distributed worldwide is necessary to mitigate the devastating health and economic impacts of pandemics like COVID-19. The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein, which mediates host cell entry of the v...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:bioRxiv
Main Authors: Gale, Emily C., Powell, Abigail E., Roth, Gillie A., Meany, Emily L., Yan, Jerry, Ou, Ben S., Grosskopf, Abigail K., Adamska, Julia, Picece, Vittoria C. T. M., d’Aquino, Andrea I., Pulendran, Bali, Kim, Peter S., Appel, Eric A.
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8020976/
https://ncbi.nlm.nih.gov/pubmed/33821276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.03.31.437792
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados